P06239 LCK_HUMAN
Gene name: LCK
Protein name: Tyrosine-protein kinase Lck
List of molecules and drugs that target protein P06239
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P06239_DB01254 | DB01254 | Dasatinib | multitarget | IC50(nM) = 0.4 Kd(nM) = 0.2 | ZBNZXTGUTAYRHI-UHFFFAOYSA-N | CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1 |
2 | P06239_DB01830 | DB01830 | AP-22408 | n/a | SPSGYTWOIGAABK-DQEYMECFSA-N | CC(=O)N[C@@H](CC1=CC=C(C(=C1)P(O)(O)=O)P(O)(O)=O)C(=O)N[C@H]1CCCCC2=CC(OCC3CCCCC3)=C(C=C12)C(N)=O | |
3 | P06239_DB02010 | DB02010 | Staurosporine | n/a | HKSZLNNOFSGOKW-FYTWVXJKSA-N | [H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC | |
4 | P06239_DB03023 | DB03023 | 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine | n/a | PBBRWFOVCUAONR-UHFFFAOYSA-O | CC(C)(C)N1[NH+]=C(C2=C1N=CN=C2N)C1=CC=C(Cl)C=C1 | |
5 | P06239_DB04003 | DB04003 | {4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid | n/a | FXUGQWABROMTDA-SBUREZEXSA-N | [H]N([H])C(=O)C1=C(OCC2CCCCC2)C=CC(=C1)[C@H](C)N([H])C(=O)[C@H](CC1=CC(=C(OCC(O)=O)C=C1)P(O)(O)=O)N([H])C(C)=O | |
6 | P06239_DB04395 | DB04395 | Phosphoaminophosphonic Acid-Adenylate Ester | n/a | PVKSNHVPLWYQGJ-FCIPNVEPSA-N | NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)NP(O)(O)=O)[C@H](O)[C@H]1O | |
7 | P06239_DB06925 | DB06925 | 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | n/a | IC50(nM) = 0.2 | YEIASMOUYNOXGA-UHFFFAOYSA-N | CC1=CC=C(C=C1C1=CC=C2N=C(N)N=CC2=C1)C(=O)NC1=CC=CC(=C1)C(F)(F)F |
8 | P06239_DB07146 | DB07146 | 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE | n/a | IC50(nM) = 210.0 | QUIQCYFSBGOBKE-UHFFFAOYSA-N | C(CN1CCNCC1)NC1=CC=NC2=C1C(=C(O2)C1=CC=CC=C1)C1=CC=CC=C1 |
9 | P06239_DB07297 | DB07297 | 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE | n/a | IC50(nM) = 81.0 | PTILEOLOGGMFCS-UHFFFAOYSA-N | C(CN1CCNCC1)NC1=C2C(OC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1 |
10 | P06239_DB08055 | DB08055 | N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine | n/a | IC50(nM) = 220.0 | NNBICZMPIJMWGC-UHFFFAOYSA-N | ClC1=C(NC2=NC=C(N3C=NC=C23)C2=CC=CC=C2)C=CC=C1 |
11 | P06239_DB08056 | DB08056 | N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine | n/a | IC50(nM) = 20.0 | KKYYLKPGILUPOA-UHFFFAOYSA-N | CC1=CC=CC(C)=C1NC1=NC=C(N2C=NC=C12)C1=CC=CC=C1 |
12 | P06239_DB08057 | DB08057 | N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine | n/a | VWJPPYCULHDHBB-HNNXBMFYSA-N | [H][C@]1(C)CN(CCN1)C1=CC=C2N=C(NC3=C(C)C=CC=C3Cl)C3=CN=CN3C2=C1 | |
13 | P06239_DB08901 | DB08901 | Ponatinib | inhibitor | IC50(nM) = 0.28 | PHXJVRSECIGDHY-UHFFFAOYSA-N | CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1 |
14 | P06239_DB09079 | DB09079 | Nintedanib | inhibitor | XZXHXSATPCNXJR-ZIADKAODSA-N | COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1 | |
15 | P06239_DB12010 | DB12010 | Fostamatinib | inhibitor | GKDRMWXFWHEQQT-UHFFFAOYSA-N | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC | |
16 | P06239_DB15035 | DB15035 | Zanubrutinib | inhibitor | RNOAOAWBMHREKO-QFIPXVFZSA-N | NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1 | |
17 | P06239_DB16656 | DB16656 | Zotiraciclib | inhibitor | VXBAJLGYBMTJCY-NSCUHMNNSA-N | CN1C\C=C\CCOC2=CC(=CC=C2)C2=CC=NC(NC3=CC=CC(C1)=C3)=N2 |